ClinConnect ClinConnect Logo
Search / Trial NCT05994638

Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy

Launched by ARONPHARMA SP. Z O. O. · Aug 15, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Radiotherapy Head And Neck Cancer Dysphagia Oral Mucositis

ClinConnect Summary

This clinical trial is studying a natural treatment made from plant extracts that are high in polyphenols, which are compounds believed to help support cancer patients. The focus is on patients who have received radiation therapy and are experiencing oral mucositis, a painful condition that causes sores in the mouth and throat. The goal is to see if this treatment can help reduce the side effects that patients face after their radiation sessions.

To be eligible for this study, participants must be between 18 and 75 years old and have been diagnosed with head and neck cancer or another type of cancer that has required radiation therapy, along with experiencing oral mucositis or dry mouth. It's important to note that individuals taking certain supplements, those with specific health conditions, or women who are pregnant or breastfeeding cannot participate. If you join the trial, you can expect to receive the new treatment and have regular check-ins to monitor your health and any changes in your symptoms. This study is currently looking for volunteers, and your participation could help improve care for future cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Women and men, 18-75 years old
  • Patients with head and neck cancer or other types of cancer after radiotherapy who suffer from oral mucositis
  • Patients with dryness in mouth
  • Signed informed consent.
  • Exclusion Criteria:
  • Intake of supplements containing plant extracts, polyphenols or anthocyanins
  • Participation in another clinical trial,
  • Women who are pregnant, planning to become pregnant during the study or breastfeeding,
  • Autoimmune disease, severe liver dysfunction, inflammatory bowel disease, tuberculosis, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplantation.
  • Hypersensitivity/allergy to any of the ingredient

About Aronpharma Sp. Z O. O.

Aronpharma sp. z o. o. is a dynamic clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development. Based in Poland, the company specializes in the design and management of clinical trials across various therapeutic areas, with a strong emphasis on quality, compliance, and patient safety. Leveraging a team of experienced professionals and a robust network of clinical sites, Aronpharma is committed to delivering reliable data and insights that contribute to the advancement of healthcare and the development of effective medical treatments.

Locations

Gdańsk, , Poland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported